DanielLeeLipsMD

Cardiology • Minneapolis, MN

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Join to view full profile

Dr. Lips is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lips' full profile

Already have an account?

Office
800 E 28th St
Minneapolis, MN 55407
Phone+1 612-775-3030

Fax+1 612-863-1681

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1989 - 1992
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1986 - 1989
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1983 - 1986
Washington University in St. Louis School of MedicineClass of 1983

Certifications & Licensure

MO State Medical License 1985 - 2026
KS State Medical License 1998 - 2025
MN State Medical License 2002 - 2025
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow (FACC) American College of Cardiology

Clinical Trials

The OMEGA Clinical Trial Start of enrollment: 2011 Oct 01
Completed
Not Applicable

Publications & Presentations

PubMed

1 citations
Sleep Deprivation in Cardiology: A Multidisciplinary Survey
Angie S. Lobo, Yader Sandoval, M. Nicholas Burke, Paul Sorajja, Michael Mooney
The Journal of Invasive Cardiology. 2019-04-15
8 citations
Prevalence, Trends, and Outcomes of Higher-Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes.
Ann Iverson, Larissa Stanberry, Peter Tajti, Ross Garberich, Amber Antos
Cardiovascular Revascularization Medicine. 2019-04-01
36 citations
NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
Jay H. Traverse, Cory Swingen, Timothy D. Henry, Jane Fox, Yale L. Wang
Circulation Research. 2019-03-01

Journal Articles

Prevalence, Trends, and Outcomes of Higher Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes☆☆☆
Ivan Chavez, M Nicholas Burke, Daniel Lips, Jay Traverse, Emmanouil S Brilakis, Anil Poulose, Michael Mooney, Paul Sorajja, Yale Wang, ScienceDirect
Meta‐Analysis of the Impact of Successful Chronic Total Occlusion Percutaneous Coronary Intervention on Left Ventricular Systolic Function and Reverse Remodeling
Ivan Chavez, Yale Wang, Emmanouil S Brilakis, Louis P Kohl, Daniel Lips, Michael Mooney, Paul Sorajja, Anil Poulose, M Nicholas Burke, Jay Traverse, Journal of Interventional Cardiology

Press Mentions

Emergency Treatment for Heart Attack Improving but Delays Still OccurSeptember 19th, 2011

Professional Memberships

American College of Cardiology - ACC
Member